Copperwynd Financial, LLC Illumina, Inc. Transaction History

Copperwynd Financial, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$92.79 - $142.53 $107,172 - $164,622	1,155 Added 42.35%	3,882 $540,000
Q3 2023 Nov 07, 2023	BUY	$128.91 - $192.44 $44,087 - $65,814	342 Added 14.34%	2,727 $374,000
Q2 2023 Aug 08, 2023	SELL	$183.43 - $232.67 $3,301 - $4,188	-18 Reduced 0.75%	2,385 $447,000
Q1 2023 Apr 28, 2023	BUY	$193.75 - $232.55 $155,775 - $186,970	804 Added 50.28%	2,403 $558,000
Q4 2022 Feb 02, 2023	SELL	$187.24 - $242.74 $46,997 - $60,927	-251 Reduced 13.57%	1,599 $323,000
Q3 2022 Nov 10, 2022	BUY	$177.23 - $227.44 $21,799 - $27,975	123 Added 7.12%	1,850 $353,000
Q2 2022 Aug 05, 2022	SELL	$181.58 - $368.0 $27,781 - $56,304	-153 Reduced 8.14%	1,727 $318,000
Q1 2022 Apr 21, 2022	BUY	$303.87 - $423.8 $103,619 - $144,515	341 Added 22.16%	1,880 $657,000
Q4 2021 Feb 04, 2022	BUY	$347.28 - $421.83 $65,288 - $79,304	188 Added 13.92%	1,539 $585,000
Q3 2021 Nov 03, 2021	BUY	$405.61 - $524.84 $57,596 - $74,527	142 Added 11.75%	1,351 $548,000
Q2 2021 Aug 12, 2021	BUY	$372.84 - $481.5 $42,503 - $54,891	114 Added 10.41%	1,209 $572,000
Q1 2021 May 06, 2021	BUY	$361.28 - $504.76 $395,601 - $552,712	1,095 New	1,095 $421,000

900

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $21.4B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Copperwynd Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Copperwynd Financial, LLC with notifications on news.